Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- CheckyesterdayChange Detected- Added related topic links for Multiple Myeloma and MedlinePlus Genetics to the Study Details page.SummaryDifference0.4%

 - Check8 days agoNo Change Detected
 - Check15 days agoChange DetectedAdded MedlinePlus Genetics topic on multiple myeloma to expand core content.SummaryDifference0.1%

 - Check22 days agoChange DetectedRemoved MedlinePlus Genetics topic on multiple myeloma, reducing genetics-focused coverage of that disease.SummaryDifference0.1%

 - Check29 days agoChange DetectedUpdated the page to announce v3.2.0 with a funding-related operating status notice, replacing the previous v3.1.0. Key impact: users are informed about potential service disruptions and where to verify status.SummaryDifference0.9%

 - Check37 days agoChange DetectedBroaden and update the page content: replace 'Plasma cell myeloma' with 'Multiple myeloma' and increment the revision to v3.1.0, indicating an updated topic scope and terminology.SummaryDifference0.1%

 - Check51 days agoChange DetectedThe page updates to v3.0.2 and removes the MedlinePlus Genetics topic 'Multiple myeloma'; the older revision note (v3.0.1) and the 'Back to Top' element are also removed.SummaryDifference0.1%

 
Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.